A Biohistorical Perspective of Typhoid and Antimicrobial Resistance

Claas Kirchhelle, Zoe Anne Dyson, Gordon Dougan

Research output: Contribution to journalArticleOtherpeer-review

Abstract

We combine methodology from history and genetics to reconstruct the biosocial history of antimicrobial resistance (AMR) in the bacterium Salmonella enterica serovar Typhi (S. Typhi). We show how evolutionary divergence in S. Typhi was driven by rising global antibiotic use and by the neglect of typhoid outside of high-income countries. Although high-income countries pioneered 1960s precautionary antibiotic regulations to prevent selection for multidrug resistance, new antibiotic classes, typhoid's cultural status as a supposedly ancient disease of "undeveloped" countries, limited international funding, and narrow biosecurity agendas helped fragment effective global collective action for typhoid control. Antibiotic-intensive compensation for weak water and healthcare systems subsequently fueled AMR selection in low- and middle-income countries but often remained invisible due to lacking surveillance capabilities. The recent rise of extensively drug-resistant typhoid bears the biosocial footprint of more than half a century of antibiotic-intensive international neglect.

Original languageEnglish
Pages (from-to)S388-S394
Number of pages7
JournalClinical Infectious Diseases
Volume69
Issue numberSupp 5
DOIs
Publication statusPublished - 1 Nov 2019
Externally publishedYes

Keywords

  • international health
  • antimicrobial resistance
  • biosecurity
  • typhoid
  • vaccination

Cite this

@article{fc1a26ca34264d42b90000ee25cb5db3,
title = "A Biohistorical Perspective of Typhoid and Antimicrobial Resistance",
abstract = "We combine methodology from history and genetics to reconstruct the biosocial history of antimicrobial resistance (AMR) in the bacterium Salmonella enterica serovar Typhi (S. Typhi). We show how evolutionary divergence in S. Typhi was driven by rising global antibiotic use and by the neglect of typhoid outside of high-income countries. Although high-income countries pioneered 1960s precautionary antibiotic regulations to prevent selection for multidrug resistance, new antibiotic classes, typhoid's cultural status as a supposedly ancient disease of {"}undeveloped{"} countries, limited international funding, and narrow biosecurity agendas helped fragment effective global collective action for typhoid control. Antibiotic-intensive compensation for weak water and healthcare systems subsequently fueled AMR selection in low- and middle-income countries but often remained invisible due to lacking surveillance capabilities. The recent rise of extensively drug-resistant typhoid bears the biosocial footprint of more than half a century of antibiotic-intensive international neglect.",
keywords = "international health, antimicrobial resistance, biosecurity, typhoid, vaccination",
author = "Claas Kirchhelle and Dyson, {Zoe Anne} and Gordon Dougan",
year = "2019",
month = "11",
day = "1",
doi = "10.1093/cid/ciz556",
language = "English",
volume = "69",
pages = "S388--S394",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "Supp 5",

}

A Biohistorical Perspective of Typhoid and Antimicrobial Resistance. / Kirchhelle, Claas; Dyson, Zoe Anne; Dougan, Gordon.

In: Clinical Infectious Diseases, Vol. 69, No. Supp 5, 01.11.2019, p. S388-S394.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - A Biohistorical Perspective of Typhoid and Antimicrobial Resistance

AU - Kirchhelle, Claas

AU - Dyson, Zoe Anne

AU - Dougan, Gordon

PY - 2019/11/1

Y1 - 2019/11/1

N2 - We combine methodology from history and genetics to reconstruct the biosocial history of antimicrobial resistance (AMR) in the bacterium Salmonella enterica serovar Typhi (S. Typhi). We show how evolutionary divergence in S. Typhi was driven by rising global antibiotic use and by the neglect of typhoid outside of high-income countries. Although high-income countries pioneered 1960s precautionary antibiotic regulations to prevent selection for multidrug resistance, new antibiotic classes, typhoid's cultural status as a supposedly ancient disease of "undeveloped" countries, limited international funding, and narrow biosecurity agendas helped fragment effective global collective action for typhoid control. Antibiotic-intensive compensation for weak water and healthcare systems subsequently fueled AMR selection in low- and middle-income countries but often remained invisible due to lacking surveillance capabilities. The recent rise of extensively drug-resistant typhoid bears the biosocial footprint of more than half a century of antibiotic-intensive international neglect.

AB - We combine methodology from history and genetics to reconstruct the biosocial history of antimicrobial resistance (AMR) in the bacterium Salmonella enterica serovar Typhi (S. Typhi). We show how evolutionary divergence in S. Typhi was driven by rising global antibiotic use and by the neglect of typhoid outside of high-income countries. Although high-income countries pioneered 1960s precautionary antibiotic regulations to prevent selection for multidrug resistance, new antibiotic classes, typhoid's cultural status as a supposedly ancient disease of "undeveloped" countries, limited international funding, and narrow biosecurity agendas helped fragment effective global collective action for typhoid control. Antibiotic-intensive compensation for weak water and healthcare systems subsequently fueled AMR selection in low- and middle-income countries but often remained invisible due to lacking surveillance capabilities. The recent rise of extensively drug-resistant typhoid bears the biosocial footprint of more than half a century of antibiotic-intensive international neglect.

KW - international health

KW - antimicrobial resistance

KW - biosecurity

KW - typhoid

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85073179500&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz556

DO - 10.1093/cid/ciz556

M3 - Article

C2 - 31612939

AN - SCOPUS:85073179500

VL - 69

SP - S388-S394

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - Supp 5

ER -